Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | 0 | uM | 10 | 156.25 | 67.09 | 76.00 | 139.25 | 0.5458 | 0.1256 | |
MDA-MB-231 | Nilotinib | 0.0033113 | uM | 10 | 156.25 | 67.09 | 71.00 | 139.25 | 0.5099 | 0.0552 |
MDA-MB-231 | Taxol | 0.00016596 | uM | 10 | 156.25 | 67.09 | 111.00 | 139.25 | 0.7971 | 0.6127 |
MDA-MB-231 | Palbociclib | 0.31623 | uM | 10 | 156.25 | 67.09 | 87.00 | 139.25 | 0.6248 | 0.2798 |
MDA-MB-231 | Palbociclib | 0.01 | uM | 10 | 156.25 | 67.09 | 132.00 | 139.25 | 0.9479 | 0.9010 |
MDA-MB-231 | Nilotinib | 0.1 | uM | 10 | 156.25 | 67.09 | 93.00 | 139.25 | 0.6679 | 0.3634 |
MDA-MB-231 | 0 | uM | 10 | 156.25 | 67.09 | 140.00 | 139.25 | 1.0054 | 1.0102 | |
MDA-MB-231 | Taxol | 0.01 | uM | 10 | 156.25 | 67.09 | 109.00 | 139.25 | 0.7828 | 0.5851 |
MDA-MB-231 | Omipalisib | 0.31623 | uM | 10 | 156.25 | 67.09 | 65.00 | 139.25 | 0.4668 | -0.0296 |
MDA-MB-231 | Nilotinib | 0.31623 | uM | 10 | 156.25 | 67.09 | 197.00 | 139.25 | 1.4147 | 1.7800 |
MDA-MB-231 | Taxol | 0.1 | uM | 10 | 156.25 | 67.09 | 95.00 | 139.25 | 0.6822 | 0.3912 |
MDA-MB-231 | Taxol | 0.00033113 | uM | 10 | 156.25 | 67.09 | 238.00 | 139.25 | 1.7092 | 2.3265 |
MDA-MB-231 | Omipalisib | 0.01 | uM | 10 | 156.25 | 67.09 | 134.00 | 139.25 | 0.9623 | 0.9284 |
MDA-MB-231 | Nilotinib | 0.01 | uM | 10 | 156.25 | 67.09 | 112.00 | 139.25 | 0.8043 | 0.6265 |
MDA-MB-231 | 0 | uM | 10 | 156.25 | 67.09 | 178.00 | 139.25 | 1.2783 | 1.5249 | |
MDA-MB-231 | Omipalisib | 3.1623 | uM | 10 | 156.25 | 67.09 | 66.00 | 139.25 | 0.4740 | -0.0154 |
MDA-MB-231 | Omipalisib | 0.0016596 | uM | 10 | 156.25 | 67.09 | 113.00 | 139.25 | 0.8115 | 0.6403 |
MDA-MB-231 | 0 | uM | 10 | 156.25 | 67.09 | 161.00 | 139.25 | 1.1562 | 1.2954 | |
MDA-MB-231 | Nilotinib | 3.1623 | uM | 10 | 156.25 | 67.09 | 103.00 | 139.25 | 0.7397 | 0.5022 |
MDA-MB-231 | Nilotinib | 10 | uM | 10 | 156.25 | 67.09 | 326.00 | 139.25 | 2.3411 | 3.4843 |
MDA-MB-231 | Palbociclib | 1 | uM | 10 | 156.25 | 67.09 | 56.00 | 139.25 | 0.4022 | -0.1576 |
MDA-MB-231 | 0 | uM | 10 | 156.25 | 67.09 | 125.00 | 139.25 | 0.8977 | 0.8052 | |
MDA-MB-231 | 0 | uM | 10 | 156.25 | 67.09 | 137.00 | 139.25 | 0.9838 | 0.9693 | |
MDA-MB-231 | 0 | uM | 10 | 156.25 | 67.09 | 155.00 | 139.25 | 1.1131 | 1.2141 | |
MDA-MB-231 | Omipalisib | 0.1 | uM | 10 | 156.25 | 67.09 | 42.00 | 139.25 | 0.3016 | -0.3589 |